Back to Awarded Treatment Trials


Awarded Trial: 18T-004

Grant ID

18T-004

Illness

Schizophrenia

Primary Drug/Intervention

probiotic microorganisms

Primary Dosage

4 grams per day

Secondary Drug Intervention

N/A

Secondary Dosage

N/A

Other Drug/Intervention

N/A

Other Dosage

N/A

Status

Preparing to start

Investigator

Iris Sommer

Sample Size

240

Duration of Study Period for Each Subject

347 days

Outcome Measurements

Functional disability as assessed with the WHO-DAS II Symptom severity as assessed with BPRS Secondary Outcomes: quality of life, recovery, side-effects, peripheral immune markers, presence/severity of parameters of metabolic syndrome

Results

N/A

Publication

N/A

Link

N/A

PI Name

Iris Sommer

Degree

N/A

Center

Neuroscience and Psychiatry

Institution

Unviersity Medical Center Groningen

Address

Deusinglaan 2

City or Town

Groningen

State or Province

N/A

Zip or Postal Code

N/A

Country

Netherlands

Email Address

i.e.c.sommer@umcg.nl